Health News Releases

  • Today April 30
November 03, 2024 11:30
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.medidata.com&esheet=54145051&newsitemid=20241031324962&lan=en-US&anchor=Medidata&index=1&md5=ae204c6a0f9fac4adb7ac338e882
(Photo: Business Wire)
November 03, 2024 10:45
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establ
November 03, 2024 10:30
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54142153&newsitemid=20241030235134&lan=en-US&anc
Rob Wojciechowski (Photo: Business Wire)
November 01, 2024 16:10
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the appointment of Rob Wojciechowski as Managing Director of the Consulting Practice across Europe and the Asia-
November 01, 2024 14:30
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fmedidata.com&esheet=54142421&newsitemid=20241029570790&lan=en-US&anchor=Medidata&index=1&md5=0177f87e5f8ba1d95a947b55a8ead5ee
October 31, 2024 09:13
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has accepted the Biologic License Application (BLA) for HLX14, an investigatio
October 30, 2024 14:40
Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54143515&newsitemid=20241029413584&lan=en-US&anchor=Parse+Biosciences&index=1&md
October 30, 2024 14:25
Naobios and Sumagen Successfully Optimize HIV Vaccine Candidate for Industrial Production
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, and Sumagen Canada Inc (Sumagen),
October 30, 2024 10:45
World Stroke Organization Launches Global Coalition to Drive Policy Action on Stroke Care
On World Stroke Day, October 29, the World Stroke Organization (WSO) announces the launch of a global coalition aimed at accelerating policy action on stroke—now the second leading cause of death and
Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences
October 29, 2024 15:25
Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences Industry
Boomi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fboomi.com%2F&esheet=54141438&newsitemid=20241028722622&lan=en-US&anchor=Boomi&index=1&md5=0797880acb2d3b33005b1492eb4e78bc)™, t
October 29, 2024 14:30
ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies,
October 29, 2024 13:50
BeiGene Mourns Death of Beloved Board Member Donald Glazer
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54142605&newsitemid=20241028061544&lan=en-US&anchor=BeiGene&index=1&md5=91bcb3b9baea32c9e4fd8e1120f
October 28, 2024 10:40
LabGenomics USA Concludes Acquisition of IMD CLIA Labs
LabGenomics USA (https://www.labgusa.com/) has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This ac
October 27, 2024 13:30
Listing on the Tokyo Stock Exchange Prime Market
Rigaku Holdings Corporation, a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), has completed its listing on the Tokyo Stock Excha
October 25, 2024 14:17
Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends
Galderma (SWX:GALD), the pure-play dermatology category leader, today announced a new edition of the Galderma Aesthetic Injector Network (GAIN) event in the Asia-Pacific region, which houses some of t
Boomi Launches New Veeva Vault Connector to Simplify Application Integration in the Life Sciences Industry
October 25, 2024 14:10
Boomi Launches New Veeva Vault Connector to Simplify Application Integration in the Life Sciences Industry
Boomi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fboomi.com%2F&esheet=54141433&newsitemid=20241024317066&lan=en-US&anchor=Boomi&index=1&md5=7d9b4c6f5795fffa95b058382b2d3658)™, t
October 25, 2024 11:38
Galderma Delivers Record Net Sales of 3.259 B USD in the First Nine Months of 2024, Demonstrates Significant Innovation Progress, Confirms and Narrows Its Full Year Net Sales Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first nine months of 2024, reporting record net sales and significant progress ac
October 24, 2024 10:00
BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issue
(Photo: Business Wire)
October 23, 2024 14:45
ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation
ANANDA Scientific Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.anandascientific.com%2F&esheet=54138297&newsitemid=20241022571870&lan=en-US&anchor=ANANDA+Scientific+Inc.&
October 21, 2024 17:20
ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™)
Galderma today announced new phase III data from the READY-4 clinical trial, demonstrating the long-term safety of RelabotulinumtoxinA (Relfydess™) for frown lines and crow’s feet after repeated injec
October 18, 2024 11:35
Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54136391&newsitemid=20241017355667&lan=en-US&anchor=Medidata&index=1&md5=d87912bb1e54e36a39a
Measuring 35x35cm, the material has been produced using the company’s newly scaled-up tissue bioreac
October 17, 2024 14:45
Bio-Engineering Scale-Up Qorium Showcases Cultivated Leather Breakthrough, Signalling a Key Step Towards Commercialisation
Cultivated leather pioneer Qorium has released footage (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fvimeo.com%2F1017020585%3Fshare%3Dcopy%23t%3D0&esheet=54135213&newsitemid=20241
(Photo: Business Wire)
October 17, 2024 14:30
ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain
ANANDA (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fanandascientific.com%2F&esheet=54135042&newsitemid=20241015941899&lan=en-US&anchor=ANANDA&index=1&md5=44a7f5c1680156e5b97b89ec
Top 10 finalist nurses for Aster Guardians Global Nursing Award 2024 (Photo: AETOSWire)
October 17, 2024 14:25
Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2024
Aster Guardians Global Nursing Award has today unveiled the top 10 finalists for 2024, one of whom will go on to win the grand title award of US $ 250,000. These 10 nurses have been shortlisted from a
October 14, 2024 16:00
Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®, receives approval from US FDA
Dong-A ST (http://en.donga-st.com/Main.da) (President/CEO Jae-Hun Jung, KRX: 170900) announced on October 11 that Imuldosa™ (usteki-numab-srlf/DMB-3115), a biosimilar referencing Stelara®, has won U.S
25 per page50 per page75 per page100 per page